Published in Osteoporos Int on March 04, 2010
Alcohol and bone: review of dose effects and mechanisms. Osteoporos Int (2011) 1.40
Aging and bone. J Dent Res (2010) 1.20
Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice. FASEB J (2011) 1.16
Hand in glove: brain and skull in development and dysmorphogenesis. Acta Neuropathol (2013) 1.04
The relation between renal function and serum sclerostin in adult patients with CKD. Clin J Am Soc Nephrol (2013) 1.03
Disruption of Kif3a in osteoblasts results in defective bone formation and osteopenia. J Cell Sci (2012) 1.01
In situ intracellular calcium oscillations in osteocytes in intact mouse long bones under dynamic mechanical loading. FASEB J (2013) 1.00
The association between the low muscle mass and osteoporosis in elderly Korean people. J Korean Med Sci (2014) 0.97
Quantitative histologic evidence of amifostine-induced cytoprotection in an irradiated murine model of mandibular distraction osteogenesis. Plast Reconstr Surg (2012) 0.96
Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. Biomed Res Int (2015) 0.92
Diagnostic measures for sarcopenia and bone mineral density. Osteoporos Int (2013) 0.92
Overexpression of Bcl2 in osteoblasts inhibits osteoblast differentiation and induces osteocyte apoptosis. PLoS One (2011) 0.92
Connexin 43 channels are essential for normal bone structure and osteocyte viability. J Bone Miner Res (2015) 0.91
Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles? Osteoporos Int (2014) 0.90
A look behind the scenes: the risk and pathogenesis of primary osteoporosis. Nat Rev Rheumatol (2015) 0.90
Induction of an osteocyte-like phenotype by fibroblast growth factor-2. Biochem Biophys Res Commun (2010) 0.87
Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy. Osteoporos Int (2015) 0.85
Effects of anti-tumor necrosis factor α agents on bone. Curr Opin Rheumatol (2012) 0.84
Do epigenetic marks govern bone mass and homeostasis? Curr Genomics (2012) 0.83
The osteocyte as a therapeutic target in the treatment of osteoporosis. Ther Adv Musculoskelet Dis (2014) 0.82
The enigmas of bone without osteocytes. Bonekey Rep (2013) 0.82
p38 MAPK Signaling in Osteoblast Differentiation. Front Cell Dev Biol (2016) 0.82
Role of apoptosis in pathogenesis and treatment of bone-related diseases. J Orthop Surg Res (2015) 0.81
Prevalence of Sarcopenia and Its Relationship with Sites of Fragility Fractures in Elderly Chinese Men and Women. PLoS One (2015) 0.81
Green fluorescent protein changes the conductance of connexin 43 (Cx43) hemichannels reconstituted in planar lipid bilayers. J Biol Chem (2011) 0.80
Synchrotron ultraviolet microspectroscopy on rat cortical bone: involvement of tyrosine and tryptophan in the osteocyte and its environment. PLoS One (2012) 0.78
Comparison of body composition between professional sportswomen and apparently healthy age- and sex-matched controls. Indian J Endocrinol Metab (2015) 0.78
Effect of the alcohol consumption on osteocyte cell processes: a molecular imaging study. J Cell Mol Med (2013) 0.77
Interaction between bone and muscle in older persons with mobility limitations. Curr Pharm Des (2014) 0.77
Vitamin D endocrine system and osteocytes. Bonekey Rep (2014) 0.77
Physiological mechanisms and therapeutic potential of bone mechanosensing. Rev Endocr Metab Disord (2015) 0.76
Mechanosignaling in bone health, trauma and inflammation. Antioxid Redox Signal (2013) 0.76
Gap Junctions and Biophysical Regulation of Bone Cells. Clin Rev Bone Miner Metab (2010) 0.76
Bone health in patients with multiple sclerosis. J Osteoporos (2011) 0.76
An ex vivo model in human femoral heads for histopathological study and resonance frequency analysis of dental implant primary stability. Biomed Res Int (2014) 0.76
3D X-ray ultra-microscopy of bone tissue. Osteoporos Int (2015) 0.76
Insights on accelerated skeletal repair in Cushing's disease. Bone Rep (2015) 0.75
Inherent physical characteristics and gene expression differences between alveolar and basal bones. Oral Surg Oral Med Oral Pathol Oral Radiol (2016) 0.75
Insights into bone health in Duchenne muscular dystrophy. Bonekey Rep (2012) 0.75
Effects of short-term Nordic walking training on sarcopenia-related parameters in women with low bone mass: a preliminary study. Clin Interv Aging (2016) 0.75
Structural and Ultrastructural Characteristics of Bone-Tendon Junction of the Calcaneal Tendon of Adult and Elderly Wistar Rats. PLoS One (2016) 0.75
GeneChip expression profiling reveals the alterations of energy metabolism related genes in osteocytes under large gradient high magnetic fields. PLoS One (2015) 0.75
Estrogen inhibits starvation-induced apoptosis in osteocytes by a redox-independent process involving association of JNK and glutathione S-transferase P1-1. FEBS Open Bio (2017) 0.75
A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid. Osteoporos Int (2017) 0.75
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol (2004) 11.23
Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature (2006) 9.40
Suppression of aging in mice by the hormone Klotho. Science (2005) 8.11
Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet (2006) 7.53
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A (2001) 6.70
Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem (2006) 6.50
Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev (2000) 6.42
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet (2001) 5.72
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res (2008) 4.82
Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem (2007) 4.74
Evolution of the Fgf and Fgfr gene families. Trends Genet (2004) 4.53
Connexins, connexons, and intercellular communication. Annu Rev Biochem (1996) 4.51
The parathyroid is a target organ for FGF23 in rats. J Clin Invest (2007) 4.47
Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res (2009) 4.40
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J (2003) 4.32
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet (2002) 4.00
A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. J Biomech (1994) 3.76
Wnt signaling in osteoblasts and bone diseases. Gene (2004) 3.72
Three-dimensional structure of a recombinant gap junction membrane channel. Science (1999) 3.69
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J (2005) 3.61
Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab (2006) 3.57
Osteocytes, mechanosensing and Wnt signaling. Bone (2008) 3.57
Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res (2006) 3.44
Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev (2005) 3.38
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest (1999) 3.30
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol (2004) 3.23
Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol (2003) 3.15
Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res (2003) 3.03
SOST is a target gene for PTH in bone. Bone (2005) 2.94
Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun (2000) 2.90
Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. Mol Biol Cell (2005) 2.75
MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics (2000) 2.75
Establishment of an osteocyte-like cell line, MLO-Y4. J Bone Miner Res (1997) 2.55
Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J Bone Miner Res (1997) 2.44
A Wnt canon orchestrating osteoblastogenesis. Trends Cell Biol (2006) 2.32
Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J Bone Miner Res (2006) 2.31
Transduction of cell survival signals by connexin-43 hemichannels. J Biol Chem (2001) 2.30
Buried alive: how osteoblasts become osteocytes. Dev Dyn (2006) 2.23
A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population. Am J Med Genet (2002) 2.21
Endocrine functions of bone in mineral metabolism regulation. J Clin Invest (2008) 2.19
Mechanotransduction and strain amplification in osteocyte cell processes. Proc Natl Acad Sci U S A (2004) 2.16
Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem (2002) 2.12
Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes. Bone (1996) 2.11
Primary cilia mediate mechanosensing in bone cells by a calcium-independent mechanism. Proc Natl Acad Sci U S A (2007) 2.10
Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab (2000) 2.08
Improved bone structure and strength after long-term mechanical loading is greatest if loading is separated into short bouts. J Bone Miner Res (2002) 2.08
Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J Bone Miner Res (2001) 2.06
Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology (2001) 1.98
Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol (2006) 1.98
E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol Cell Biol (2006) 1.98
Ultrastructure of the osteocyte process and its pericellular matrix. Anat Rec A Discov Mol Cell Evol Biol (2004) 1.96
Wnt signaling and osteoblastogenesis. Rev Endocr Metab Disord (2006) 1.94
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev (2005) 1.88
Osteocytes as dynamic multifunctional cells. Ann N Y Acad Sci (2007) 1.86
MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone (2004) 1.79
Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs. Am J Physiol Cell Physiol (2005) 1.70
Cilia-like structures and polycystin-1 in osteoblasts/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression. J Biol Chem (2006) 1.68
Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo. J Bone Miner Res (2008) 1.68
Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins. Mol Cell Biol (2002) 1.60
Isolation of a gene sequence induced later by tumor-promoting 12-O-tetradecanoylphorbol-13-acetate in mouse osteoblastic cells (MC3T3-E1) and expressed constitutively in ras-transformed cells. Cell Growth Differ (1990) 1.58
Mechanotransduction in bone: do bone cells act as sensors of fluid flow? FASEB J (1994) 1.57
The many adaptations of bone. J Biomech (2003) 1.56
Pathogenic role of Fgf23 in Dmp1-null mice. Am J Physiol Endocrinol Metab (2008) 1.55
Gap junctions in skeletal development and function. Biochim Biophys Acta (2005) 1.53
A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism. J Biol Chem (2006) 1.52
Adaptation of connexin 43-hemichannel prostaglandin release to mechanical loading. J Biol Chem (2008) 1.52
Identification of osteoblast/osteocyte factor 45 (OF45), a bone-specific cDNA encoding an RGD-containing protein that is highly expressed in osteoblasts and osteocytes. J Biol Chem (2000) 1.52
Pulsating fluid flow increases nitric oxide (NO) synthesis by osteocytes but not periosteal fibroblasts--correlation with prostaglandin upregulation. Biochem Biophys Res Commun (1995) 1.51
Mechanosensation and Transduction in Osteocytes. Bonekey Osteovision (2006) 1.50
Osteocyte lacunae tissue strain in cortical bone. J Biomech (2005) 1.49
Early strain-related changes in enzyme activity in osteocytes following bone loading in vivo. J Bone Miner Res (1989) 1.43
Osteocyte differentiation in the tibia of newborn rabbit: an ultrastructural study of the formation of cytoplasmic processes. Acta Anat (Basel) (1990) 1.43
The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res (1998) 1.39
Gap junctions regulate extracellular signal-regulated kinase signaling to affect gene transcription. Mol Biol Cell (2004) 1.33
Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression. Mol Endocrinol (2002) 1.32
Do osteocytes contribute to bone mineral homeostasis? Osteocytic osteolysis revisited. Bone (2008) 1.32
Mechanical strain stimulates nitric oxide production by rapid activation of endothelial nitric oxide synthase in osteocytes. J Bone Miner Res (1999) 1.31
Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. Exp Cell Res (2004) 1.28
Osteocyte function, osteocyte death and bone fracture resistance. Mol Cell Endocrinol (2000) 1.25
Identification of apoptotic changes in osteocytes in normal and pathological human bone. Bone (1997) 1.24
Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G/H synthase mRNA expression in primary mouse bone cells. J Bone Miner Res (1997) 1.23
Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone. J Mol Histol (2007) 1.19
Bone formation by osteocytes. Am J Physiol (1971) 1.17
Osteocyte morphology in fibula and calvaria --- is there a role for mechanosensing? Bone (2008) 1.17
Mechanical stimulation in vivo reduces osteocyte expression of sclerostin. J Musculoskelet Neuronal Interact (2006) 1.16
Osteocyte density changes in aging and osteoporosis. Bone (1996) 1.14
Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading. Bone (2006) 1.13
Osteocytic osteolysis observed in rats to which parathyroid hormone was continuously administered. J Bone Miner Metab (2004) 1.13
Downregulation of SOST/sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes. J Musculoskelet Neuronal Interact (2006) 1.13
The osteocyte lineage. Arch Biochem Biophys (2008) 1.12
Osteocyte hypoxia: a novel mechanotransduction pathway. Am J Physiol (1999) 1.11
The structure of bone tissues and the cellular control of their deposition. Ital J Anat Embryol (1997) 1.11
Skeletal strain and the functional significance of bone architecture. Calcif Tissue Int (1984) 1.10
Osteocyte morphology in human tibiae of different bone pathologies with different bone mineral density--is there a role for mechanosensing? Bone (2009) 1.07
Distinct responses of different populations of bone cells to mechanical stress. Endocrinology (1996) 1.07
Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1. Eur J Endocrinol (2008) 1.05
Knee loading stimulates cortical bone formation in murine femurs. BMC Musculoskelet Disord (2006) 1.05
Osteocytic expression of mRNA for c-fos and IGF-I: an immediate early gene response to an osteogenic stimulus. Am J Physiol (1996) 1.04
Submicroscopic structure and functional aspects of the osteocyte. Clin Orthop Relat Res (1968) 1.03
Calcium response in single osteocytes to locally applied mechanical stimulus: differences in cell process and cell body. J Biomech (2009) 1.02
[Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases]. Rev Rhum Mal Osteoartic (1987) 3.40
Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthritis Cartilage (2006) 1.77
Septic arthritis of lumbar facet joints. A review of six cases. Rev Rhum Engl Ed (1997) 1.51
Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet. Osteoporos Int (2011) 1.45
Preserved bone health in adolescent elite rhythmic gymnasts despite hypoleptinemia. Horm Res (2007) 1.43
Alcohol and bone: review of dose effects and mechanisms. Osteoporos Int (2011) 1.40
Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results. Osteoporos Int (2007) 1.21
Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture. Bone (2007) 1.17
Effect of physical training on bone mineral density in prepubertal girls: a comparative study between impact-loading and non-impact-loading sports. Osteoporos Int (1998) 1.14
Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling. Toxicol Appl Pharmacol (2007) 1.07
Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. Bone (2005) 1.04
Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions. J Cell Physiol (2008) 1.04
Grafting RGD containing peptides onto hydroxyapatite to promote osteoblastic cells adhesion. J Mater Sci Mater Med (2004) 1.03
Fractal dimension of trabecular bone projection texture is related to three-dimensional microarchitecture. J Bone Miner Res (2000) 1.02
Fractal analysis of trabecular bone texture on radiographs: discriminant value in postmenopausal osteoporosis. Osteoporos Int (1998) 1.02
Function of linear and cyclic RGD-containing peptides in osteoprogenitor cells adhesion process. Biomaterials (2002) 0.99
Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats. J Pharmacol Exp Ther (2006) 0.98
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis. Osteoporos Int (2011) 0.94
Cyclo-(DfKRG) peptide grafting onto Ti-6Al-4V: physical characterization and interest towards human osteoprogenitor cells adhesion. Biomaterials (2004) 0.92
Assessment of trabecular bone microarchitecture by two different x-ray microcomputed tomographs: a comparative study of the rat distal tibia using Skyscan and Scanco devices. Med Phys (2009) 0.91
Trabecular and cortical bone separately assessed at radius with a new ultrasound device, in a young adult population with various physical activities. Bone (2010) 0.90
[Pseudoseptic arthritis and bacterid of Andrews]. Rev Rhum Mal Osteoartic (1984) 0.89
Clinical interest of bone texture analysis in osteoporosis: a case control multicenter study. Osteoporos Int (2008) 0.88
Increase in vertebral body size in postmenopausal women with osteoporosis. Bone (2010) 0.87
Laws' masks descriptors applied to bone texture analysis: an innovative and discriminant tool in osteoporosis. Skeletal Radiol (2008) 0.87
Doping dose of salbutamol and exercise: deleterious effect on cancellous and cortical bones in adult rats. J Appl Physiol (1985) (2006) 0.86
A new method for three-dimensional skeleton graph analysis of porous media: application to trabecular bone microarchitecture. J Microsc (2000) 0.86
Biomechanical properties of human os calcanei: relationships with bone density and fractal evaluation of bone microarchitecture. J Biomech (1998) 0.86
Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study. Hum Reprod (2003) 0.85
Osteopenia in patients infected by the human immunodeficiency virus. A case control study. Joint Bone Spine (2002) 0.84
Low bone accrual is associated with osteocyte apoptosis in alcohol-induced osteopenia. Bone (2011) 0.84
The role of muscle strength & activation patterns in patellofemoral pain. Clin Biomech (Bristol, Avon) (2013) 0.83
Alternaria infection of the skin and joints. A report of two cases involving the hand. Rev Rhum Engl Ed (1999) 0.83
Tyrosine phosphorylation of the erythropoietin receptor: role for differentiation and mitogenic signal transduction. Blood (1995) 0.83
[Destructive arthritis and Behçet's syndrome]. Ann Med Interne (Paris) (1982) 0.83
Does exercise modify the effects of zoledronic acid on bone mass, microarchitecture, biomechanics, and turnover in ovariectomized rats? Calcif Tissue Int (2009) 0.82
Bone material acquisition and somatic development in highly trained girl gymnasts. Acta Paediatr (1999) 0.82
Skull bone mass deficit in prepubertal highly-trained gymnast girls. Int J Sports Med (1999) 0.82
Fractal analysis of bone texture on os calcis radiographs compared with trabecular microarchitecture analyzed by histomorphometry. Calcif Tissue Int (1998) 0.81
Lean tissue mass is a better predictor of bone mineral content and density than body weight in prepubertal girls. Rev Rhum Engl Ed (1998) 0.81
Side-to-side and within-side variability of 3D bone microarchitecture by conventional micro-computed tomography of paired iliac crest biopsies. Bone (2008) 0.81
Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporos Int (2002) 0.81
Doping dose of salbutamol and exercise training: impact on the skeleton of ovariectomized rats. J Appl Physiol (1985) (2007) 0.80
[Association of Behcet's syndrome and ankylosing spondylitis]. Ann Med Interne (Paris) (1982) 0.80
Preparation and biological properties of monoclonal antibodies against human erythropoietin. Hybridoma (1993) 0.80
Fractal analysis of trabecular bone texture on calcaneus radiographs: effects of age, time since menopause and hormone replacement therapy. Osteoporos Int (2002) 0.80
Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS). Curr Med Res Opin (2014) 0.79
Long-term corticosteroid therapy induces mild changes in trabecular bone texture. J Bone Miner Res (2000) 0.79
Genetic algorithm and image processing for osteoporosis diagnosis. Conf Proc IEEE Eng Med Biol Soc (2010) 0.79
Effect of specimen conditioning on the microarchitectural parameters of trabecular bone assessed by micro-computed tomography. Phys Med Biol (2006) 0.79
Glucocorticoid-induced osteoporosis: is the bone density decrease the only explanation? Joint Bone Spine (2000) 0.79
Centrosome fine ultrastructure of the osteocyte mechanosensitive primary cilium. Microsc Microanal (2012) 0.78
Structure of the erythropoietin receptor. Proc Soc Exp Biol Med (1994) 0.77
Anisotropy measurements obtained by fractal analysis of trabecular bone at the calcaneus and radius. Rev Rhum Engl Ed (1996) 0.77
Hypoleptinaemia in extreme body mass models: the case of international rugby players. J Sci Med Sport (2010) 0.77
Primary bone oxalosis: the roles of oxalate deposits and renal osteodystrophy. Bone (1987) 0.76
Cephalometric assessment of craniofacial dysmorphologies in relation with Msx2 mutations in mouse. Orthod Craniofac Res (2014) 0.76
[Monoarthritis symptomatic of adjacent bone tumors. Study of 5 cases]. Rev Rhum Mal Osteoartic (1984) 0.75
[Lower costovertebral arthritis in rheumatic pelvispondylitis. Pseudourologic manifestation]. Rev Rhum Mal Osteoartic (1987) 0.75
[Lipid microcrystals and other rare crystals in the joints]. Rev Prat (1994) 0.75
[Costo-vertebral arthrosis disclosed by pseudo-visceral pains]. Rev Rhum Mal Osteoartic (1989) 0.75
Eosinophilic synovitis in patients with dermatographism. Arthritis Rheum (1987) 0.75
Functionalization of biomaterials and cell to cell communication. Biomed Mater Eng (2006) 0.75
[Arthropathies of the limbs in dialyzed renal failure patients]. Presse Med (1987) 0.75
An epidemiological study of diagnostic and therapeutic strategies in office practice patients with subacute or chronic pain in the thoracic or low back. Comparison of practices in primary care and rheumatology settings. Rev Rhum Engl Ed (1997) 0.75
Tibial subchondral bone mineral density: sources of variability and reproducibility. Osteoarthritis Cartilage (2013) 0.75
[Pseudosciatica manifesting a tibial localization of Forestier's hyperostosis]. Nouv Presse Med (1982) 0.75
[Physiology of bone tissue and pharmacologic applications]. Soins (1984) 0.75
[Calcium oxalate microcrystalline arthropathy in primary oxalosis]. Rev Rhum Mal Osteoartic (1985) 0.75
[Value of the measurement of intra-articular lactates. Contribution to the diagnosis of septic arthritis. Interpretation of 370 evaluations]. Rev Rhum Mal Osteoartic (1985) 0.75
[Andrews' bacterids and pseudoseptic arthritis]. Ann Dermatol Venereol (1983) 0.75
[Osteoarticular pathology, hypercalcemia and adrenal insufficiency. Analysis of 113 cases of adrenal insufficiency]. Ann Endocrinol (Paris) (1986) 0.75
[Osteoporosis. Epidemiology, etiology, diagnosis, prevention]. Rev Prat (2000) 0.75
[Evolution of connective tissue diseases with anti-ribonucleoprotein antibodies (in 28 patients) (author's transl)]. Ann Med Interne (Paris) (1982) 0.75
[Diphosphonates]. Nouv Presse Med (1982) 0.75
[Diffuse corticoid-sensitive cerebral arteritis (author's transl)]. Ann Med Interne (Paris) (1980) 0.75
[Porphyria]. Nouv Presse Med (1981) 0.75
[Lethal forms of connective tissue disease with antiribonucleoprotein antibodies (author's transl)]. Nouv Presse Med (1982) 0.75
Simulation of osteoporosis bone changes: effects on the degree of anisotropy. Adv Exp Med Biol (2001) 0.75
Osteoclast cytomorphometry in patients with femoral neck fracture. Pathol Res Pract (1996) 0.75
Beta-2-microglobulin amyloidosis as a complication of peritoneal dialysis treatment. Clin Nephrol (1988) 0.75
[Osteoarticular manifestations in adrenal insufficiency]. Rev Rhum Mal Osteoartic (1984) 0.75
Exercise and zoledronic acid on lipid profile and bone remodeling in ovariectomized rats: a paradoxical negative association? Lipids (2010) 0.75
[Eosinophilic arthritis and general review of the significance of articular eosinophilia]. Rev Rhum Mal Osteoartic (1983) 0.75
Rapidly progressive idiopathic chondrolysis simulating tuberculosis of the shoulder. J Rheumatol (1983) 0.75
[Histiocytoses, uncommon diseases of unknown etiology and fatal development]. Nouv Presse Med (1980) 0.75
[Bone evaluation in ten adults with cutaneous mastocytosis]. Ann Dermatol Venereol (2002) 0.75
[Hypercalcemia in granulomatous diseases: a dysfunction of vitamin D metabolism]. Presse Med (1985) 0.75
Shape classification techniques for discrete 3D porous media. Application to trabecular bone. Conf Proc IEEE Eng Med Biol Soc (2007) 0.75
[Influence of pregnancy and the hormonal status on rheumatoid arthritis]. Presse Med (1983) 0.75
[Convulsions during prolonged treatment with ofloxacin]. Rev Med Interne (1993) 0.75
[Joint diseases in dialyzed patients]. Presse Med (1987) 0.75
[Tenosynovitis of the wrist caused by atypical mycobacteria. Apropos of 2 cases]. Rev Rhum Mal Osteoartic (1986) 0.75
[Chronic arthritis in palmo-plantar pustulosis. Bacterid of Andrews]. Rev Rhum Mal Osteoartic (1986) 0.75
[Eosinophil monoarthritis in allergic patients]. Presse Med (1984) 0.75